期刊文献+

碳酸酐酶Ⅸ和低氧诱导因子-1α在非小细胞肺癌组织中的表达及其临床意义

Expression of Carbonic Anhydrase Ⅸ and Hypoxia-inducible Factor-1α in Non-Small Cell Lung Cancer and Its Significance
下载PDF
导出
摘要 【目的】研究碳酸酐酶Ⅸ(CAⅨ)和低氧诱导因子1α(HIF-1α)在非小细胞肺癌(NSCLC)中的表达及意义。【方法】检测80例NSCLC手术标本中的CAⅨ和HIF-1α表达,分析其在癌组织中表达与临床、病理之间的关系。【结果】NSCLC中CAⅨ和HIF1α的表达率分别为71.25%及66.25%,均显著高于正常肺组织(P〈0.01)。CAⅨ在NSCLC的表达与患者临床特征、病理类型无关(P〉0.05),但CAⅨ在淋巴结转移组的阳性表达率明显高于无淋巴结转移组(P〈0.05);TNM分期Ⅲ~Ⅳ期的cAⅨ阳性表达率高于TNMⅠ~Ⅱ期的CAⅨ阳性表达率(P〈0.05)。而HIF-1α在NSCLC中的表达与患者临床特征、病理类型和临床分期及淋巴结转移均无关(P〉0.05);CAⅨ和HIF-1α在非小细胞肺癌组织中的表达相关性不强(P〉0.05)。【结论】CAIX参与了NSCLC的发生、发展和侵袭转移,其可能成为抗肿瘤的新靶点。 [Objective] To investigate the expression of carbonic anhydrase Ⅸ(CA Ⅸ ) and hypoxia induc ible factor-1α(HIF-1α) in non-small cell lung cancer(NSCLC) and its significance. [Methods]The expressions of CA ⅨX and HIF-1α in surgical specimens of 80 patients with NSCLC were measured. The relationship of the expressions with clinical features and pathology was analyzed. [Results]The expression of CA Ⅸ and HIF-1α in NSCLC was 71.25% and 66.25 %, respectively, which were significantly higher than those in normal lung tissues( P 〈0.01). The expression of CA Ⅸ in NSCLC had no correlation with clinical features and patholog- ical types( P 〉0. 05), but the positive expression of CA Ⅸ in lymph node metastasis group was obviously higher than that in non-metastasis group( P 〈0.05). The positive expression of CA Ⅸ in stage TⅢ -Ⅳ was higher than that in stage TⅠ-Ⅲ( P 〈0.05). The expression of HIF-1αin NSCLC had no correlation with clinical features, pathological types, clinical stage and lymph node metastasis( P 〉0.05). The correlation be- tween CA Ⅸ and HIF-1α in NSCLC tissue is not strong( P〉0.05). [Conclusion]CA Ⅸ involves in the path- ogenesis, development, invasion and metastases of MSCLC, and may be a new target of antitumor therapy.
出处 《医学临床研究》 CAS 2012年第7期1228-1230,1234,共4页 Journal of Clinical Research
关键词 非小细胞肺/病理学 碳酸脱水酶/分析 低氧 Carcinoma, non-small-cell lung/PA carbonate dehydratase/AN anoxia
  • 相关文献

参考文献7

  • 1Potter C, Harris AL. Hypoxia inducible carbon ie anhydrase IX, marker of tumour hypoxia, survival pathway and therapy target[J]. Cell Cycle ,2004, 3(2) : 164-167.
  • 2Le QT,Chen E, Salim A, et al . An evaluation of tumor oxy- genation and gene expression in patients with early stage non- small cell lung cancers[J]. CAin Cancer Res ,2006, 12 ( 5 ) : 1507- 1514.
  • 3Giatromanolaki A, Koukourakis MI, Sivridis E. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenicpathways and independently to poor outcome in non-small cell lung cancer[J]. Cancer Res ,2001, 61(21) : 7992-7998.
  • 4Swin son DE, J ones JL, Richardson D, et at . Carbonic anhy- drase expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non- small- cell lung cancer[J]. J Clin Oncol ,2003, 21(3) : 473-482.
  • 5周文斌,白明,金阳,等.非小细胞肺癌组织碳酸酐酶和VEGF表达及其临床意义的探讨[J].中国肿瘤防治杂志,2008,15(16),1251-1254.4.
  • 6Ravi R, Mookerjee B, Bhujwalla ZM, et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia in ducihle factor 1 alpha[J].Genes Dev , 2000,14 : 34-44.
  • 7Kim S J, Rabbani ZN, Dewhirst MW, et al . Expression of HIF-1 alpha, CA IX, VEGF, and MMP-9 in surgically resec- ted non-small cell lung eaneer[J]. Lung Cancer , 2005,49 (3) : 325-335.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部